Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: A pilot study

Obstetrics and Gynecology

Volumn 71, Issue 3, 1988, Pages 344-348

  Benedetti Panici, P ^a   Scambia, G ^a   Greggi, S ^a   Di Roberto, P ^a   Baiocchi, G ^a   Mancuso, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; UTERINE CERVIX CARCINOMA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE MARROW; CARCINOMA; CERVIX NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMAN; HYSTERECTOMY; METHOTREXATE; PILOT PROJECTS;

EID: 0023742746     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ballon SC, Berman ML, LaGasse LD, et al: Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol 57:90, 1981
2. Durrance FY, Fletcher GH, Rutledge FN: Analysis of central recurrent disease in stage I and II squamous cell carcinomas of cervix on intact uterus. AJR 106:831, 1969
3. Jolles B: Long term results of treatment of carcinoma of cervix. Br J Obstet Gynaecol 87:315, 1980
4. Kottmeier HL: Annual report of the results of treatment in gynecologic cancer. Stockholm, International Federation of Gynecology and Obstetrics, Pogo Print, 1979
5. Nori D, Valentine E, Hilaris BS: The role of para-aortic node irradiation in the treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys 11:1469, 1985
6. Dargent D, Frobert JL, Bean G: V Factor (tumor volume) and T Factor (FIGO classification) in the assessment of cervix cancer prognosis: The risk of lymph node spread. Gynecol Oncol 22:15, 1985
7. Barmeir E, Langer O, Levy JI, et al: Unusual skeletal metastases in carcinoma of the cervix. Gynecol Oncol 20:307, 1985
8. Kilgore LC, Orr JW, Hatch KD, et al: Peritoneal cytology in patients with squamous cell carcinoma of the cervix. Gynecol Oncol 19:24, 1984
9. Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163, 1979
10. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221, 1982
11. Rosen G, Marcove RC, Huvos AG, et al: Primary osteogenic sarcoma: Eight-years experience with adjuvant chemotherapy. J Cancer Res Clin Oncol 106(suppl):55, 1983
12. Elias EG, Chretien PB, Monuard E, et al: Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck. Cancer 43:1025, 1979
13. Kish J, Drelichman A, Jacobs J, et al: Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 66:471, 1982
14. Kim DS, Moon H, Kang KJ: Primary chemotherapy and postoperative adjuvant chemotherapy in the treatment of squamous cell carcinoma of the uterine cervix. Gynecol Oncol 22:59, 1985
15. Belinson JL, Stewart JA, Richards AL, et al: Bleomycin, vincristine, mitomycin-C and cisplatin in the management of gynaecological squamous cell carcinomas. Gynecol Oncol 20:387, 1985
16. Friedlander ML, Atkinson K, Copplesori JMV, et al: The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study. Gynecol Oncol 19:1, 1984
17. Friedlander ML, Keye SB, Sullivan A, et al: Cervical carcinoma: A drug responsive tumor-experience with combined cisplatin, vinblastine and bleomycin therapy. Gynecol Oncol 16:275, 1983
18. Roberts SA, Morley GW, Natale RB, et al: Combination cisplatin and dichloromethotrexate in patients with advanced or recurrent cervical cancer: A preliminary report. Gynecol Oncol 19:194, 1984
19. Choo YJ, Choy TK, Wong LC, et al: Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma. Gynecol Oncol 23:94, 1986
20. Meanwell CA, Mould JJ, Blackledge G, et al: Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 70:727, 1986
21. Prestayko AW, d'Aoust JC, Issell BF, et al: Cisplatin (cisdi-amminedichloroplatinum II). Cancer Treat Rev 6:17, 1979
22. Alberts DS, Martinbeau PW, Surwit EA, et al: Mitomycin-C, bleomycin, vincristine and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix. Cancer Clin Trials 4:313, 1981
23. Di Saia PJ, Rich WM: Advanced and recurrent carcinoma of the cervix, Gynecologic Oncology, Fundamental Principles and Clinical Practice. Edited by M Coppleson. London, Churchill Livingstone, 1981, p 520
24. Piver MS, Rutledge F, Smith JP: Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265, 1974
25. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication no. 48, Geneva, 1979
26. Sardi JE, Di Paola GR, Cahan A, et al: A possible new trend in the management of the carcinoma of the cervix uteri. Gynecol Oncol 25:139, 1986
27. Chung CK, Nahhas WA, Strykew VA, et al: Analysis of factors contributing to treatment failures in stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 138:550, 1980
28. Benedetti Panici P, Di Roberto P, Greggi S, et al: Squamous cervical cancer at stage IB and II: A ten years experience, analysis of 231 cases. Eur J Gynaecol Oncol 2:76, 1987
29. Delgado G: Stage IB squamous cancer of the cervix: The choice of treatment. Obstet Gynecol Surv 33:174, 1978